Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome

Yun-long Wang; Dong-qing An; Ning Ma; Meng Zhu; Hong-yan Sun

doi:10.1007/s11655-009-0337-z

Your Location：

Home >

Browse articles >

Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome

Updated：2021-08-27

- Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome
- Chinese Journal of Integrative Medicine Vol. 15, Issue 5, Pages: 337-340(2009)
- Affiliations：
  
  Traditional Chinese Medicine College of Xinjiang Medical University, Urumiqi,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-009-0337-z
  CLC：
- Published：2009，
  
  Published Online：3 October 2009，
Scan for full text
Wang, Yl., An, Dq., Ma, N. et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome., Chin. J. Integr. Med. 15, 337–340 (2009). https://doi.org/10.1007/s11655-009-0337-z

Yun-long Wang, Dong-qing An, Ning Ma, et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome. [J]. Chinese Journal of Integrative Medicine 15(5):337-340(2009)
Wang, Yl., An, Dq., Ma, N. et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome., Chin. J. Integr. Med. 15, 337–340 (2009). https://doi.org/10.1007/s11655-009-0337-z DOI：

Yun-long Wang, Dong-qing An, Ning Ma, et al. Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome. [J]. Chinese Journal of Integrative Medicine 15(5):337-340(2009) DOI： 10.1007/s11655-009-0337-z.

摘要

To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease (CHD) of turbidity-phlegm blocking syndrome (TPB)

and to study its acting mechanism. Plasma levels of thrombosis-associated factors

including Von Willebrand factor: (vWF)

D-dimer

and fibrinogen (Fg)

in 85 patients of CHD with TPB

93 with CHD of non-TPD

and 89 healthy persons were detected and compared. Levels of the three factors were increased in all the CHD: patients

and were higher in TPB patients than in non-TPB patients (P<0.01 or P<0.05). The TPB: syndrome in CHD patients was closely related to the blood coagulation-fibrinolytic system; they might be in pre-thrombosis state

and the plasma levels of vWF

D-dimer

and Fg could be taken as the objective indices for thrombosis differentiation of TPB syndrome in CHD patients.

Abstract

To preliminarily explore the relationship between thrombosis and its associated factors in patients with coronary heart disease (CHD) of turbidity-phlegm blocking syndrome (TPB)

and to study its acting mechanism. Plasma levels of thrombosis-associated factors

including Von Willebrand factor: (vWF)

D-dimer

and fibrinogen (Fg)

in 85 patients of CHD with TPB

93 with CHD of non-TPD

and 89 healthy persons were detected and compared. Levels of the three factors were increased in all the CHD: patients

and the plasma levels of vWF

D-dimer

and Fg could be taken as the objective indices for thrombosis differentiation of TPB syndrome in CHD patients.

关键词

coronary heart diseaseturbidity-phlegm bocking syndromevon Willebrand factorD-dimerFibrinogen

Keywords

coronary heart diseaseturbidity-phlegm bocking syndromevon Willebrand factorD-dimerFibrinogen

references

Wang ZY, Li JZ, Ruan CG, Song JJ, Wang HL, Han ZC eds. Thrombosis and hemostasis: basic principles and clinical practice. 4th ed. Shanghai: Shanghai Scientific and Technical Publishers; 2004:529–531.

Chinese Society of Cardiovascular Diseases, Chinese Medical Association. Guidance for diagnosis and treatment of chronic stable angina pectonis. Chin J Cardiol (Chin) 2007;35:195–200.

Chinese Society of Cardiovascular Diseases. Guidance for diagnosis and treatment of unstable angina and non-ST elevated myocardial infarction. Chin J Cardiol (Chin) 2007; 36:1–6.

Zheng XY, ed. Guiding principle of clinical research on new drugs of Chinese medicine. Beijng: China Press of Traditional Chinese Medicine; 2002:68–73.

Zhao MF, An DQ. Preliminary investigation on syndromes of dirty phlegm stagnation of chest stuffiness in Xinjiang as well as its prevention and treatment. Xinjiang J Tradit Chin Med (Chin) 2008; 26:84–85.

Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Circulation 2004;109:1343–1348.

Wang R, Hu DN. Significance of D-dimer and fibrinogen in patients with different kinds of coronary heart disease.Chin Med Herald (Chin) 2006; 35:157–158.

Zheng YS, Zheng QP, Duan LF, Zhang LP. Relationships between plasma D-dimer and coronary heart disease. J Clin Cardiol (Chin) 2004; 20:83–85.

An DQ, Zhao MF, Zheng J, Hu JX. Discussion on chest fullness of phlegm-turbidity stagnation syndrome in Xinjiang. Xinjiang J Tradit Chin Med (Chin) 2007; 2:1–2.

FULL TEXT LINK

More>

Views

370

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effect of Tongmai Jiangzhi oral liquid on serum P-selectin, von Willebrand factors and D-dimer in patients with atherosclerosis

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Study on correspondence between prescription and syndrome and the essence of phlegm and blood stasis syndrome in coronary heart disease based on metabonomics

Summary of 2011 Integrative Medical Doctors Conference

Related Author

No data

Related Institution

Medical Colloge, Zhengzhou University

School of Medicine, Zhengzhou Railway Advanced Professional College

Henan Chinese Medical College

Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Academy of Chinese Medical Sciences

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰